Literature DB >> 19033247

Cardiac tamponade in diarrhoea-positive haemolytic uraemic syndrome.

Javed Mohammed1, Guido Filler, April Price, Ajay P Sharma.   

Abstract

The spectrum of extra-renal involvement secondary to diarrhoeal (D+) haemolytic uraemic syndrome (HUS) includes neurological, gastrointestinal, hepatic, pancreatic and cardiac complications. Among the cardiac complications, myocardial injury has been more commonly reported with HUS. Literature is scarce on HUS-associated pericardial involvement. We report a HUS-induced significant pericardial effusion that resulted in a cardiac tamponade. We also discuss the diagnostic and therapeutic implications of this complication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19033247     DOI: 10.1093/ndt/gfn649

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Ultrasound findings in EHEC-associated hemolytic-uremic syndrome and their clinical relevance.

Authors:  Ansgar Reising; Carsten Hafer; Marcus Hiss; Jan T Kielstein; Jan Menne; Faikah Gueler; Jan Beneke; Silvia Linnenweber-Held; Hermann Haller; Gunilla Einecke
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

Review 2.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

3.  Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy.

Authors:  D Lerner; C Dandoy; R Hirsch; B Laskin; S M Davies; S Jodele
Journal:  Bone Marrow Transplant       Date:  2014-03-17       Impact factor: 5.483

Review 4.  A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.

Authors:  Sonata Jodele; Benjamin L Laskin; Christopher E Dandoy; Kasiani C Myers; Javier El-Bietar; Stella M Davies; Jens Goebel; Bradley P Dixon
Journal:  Blood Rev       Date:  2014-11-28       Impact factor: 8.250

Review 5.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

Review 6.  Direct cardiac involvement in childhood hemolytic-uremic syndrome: case report and review of the literature.

Authors:  Davide Rigamonti; Giacomo D Simonetti
Journal:  Eur J Pediatr       Date:  2016-09-23       Impact factor: 3.183

7.  Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).

Authors:  Myda Khalid; Sharon Andreoli
Journal:  Pediatr Nephrol       Date:  2018-11-01       Impact factor: 3.714

8.  HUS-induced cardiac and circulatory failure is reversible using cardiopulmonary bypass as rescue.

Authors:  René F Andersen; Jesper V Bjerre; Johan V Povlsen; Mette Veien; Konstantinos Kamperis; Søren Rittig
Journal:  Pediatr Nephrol       Date:  2017-08-05       Impact factor: 3.714

9.  Cardiac Manifestation among Children with Hemolytic Uremic Syndrome.

Authors:  Emily Sanders; Clare C Brown; Richard T Blaszak; Brendan Crawford; Parthak Prodhan
Journal:  J Pediatr       Date:  2021-04-02       Impact factor: 6.314

Review 10.  Extra-renal manifestations of complement-mediated thrombotic microangiopathies.

Authors:  Johannes Hofer; Alejandra Rosales; Caroline Fischer; Thomas Giner
Journal:  Front Pediatr       Date:  2014-09-08       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.